| 1 | 1 | | LRB-2019/1 |
|---|
| 2 | 2 | | CMH:klm |
|---|
| 3 | 3 | | 2023 - 2024 LEGISLATURE |
|---|
| 4 | 4 | | 2023 ASSEMBLY JOINT RESOLUTIO N 13 |
|---|
| 5 | 5 | | March 6, 2023 - Introduced by Representatives SINICKI, CABRERA, BALDEH, CONLEY, |
|---|
| 6 | 6 | | DRAKE, EDMING, EMERSON, JACOBSON, JOERS, MOORE OMOKUNDE, MURPHY, |
|---|
| 7 | 7 | | ORTIZ-VELEZ, OHNSTAD, PALMERI, SHANKLAND, SHELTON and SUBECK, |
|---|
| 8 | 8 | | cosponsored by Senators COWLES, HESSELBEIN, JACQUE, LARSON and SPREITZER. |
|---|
| 9 | 9 | | Referred to Committee on Rules. |
|---|
| 10 | 10 | | ***AUTHORS SUBJECT TO CHANGE*** |
|---|
| 11 | 11 | | Relating to: designating June 2023 as Myasthenia Gravis Awareness Month. |
|---|
| 12 | 12 | | Whereas, myasthenia gravis (MG) is an autoimmune neuromuscular disease |
|---|
| 13 | 13 | | that causes chronic weakness, in which antibodies attack receptors in the body and |
|---|
| 14 | 14 | | prevent muscle contraction; and |
|---|
| 15 | 15 | | Whereas, MG frequently weakens muscles that control eye movement, facial |
|---|
| 16 | 16 | | expressions, and swallowing, and its symptoms may include blurred vision, speech |
|---|
| 17 | 17 | | impairment, difficulty chewing, shortness of breath, an unstable gait, and a |
|---|
| 18 | 18 | | weakened grip; and |
|---|
| 19 | 19 | | Whereas, a diagnosis of MG may be missed or delayed because it shares |
|---|
| 20 | 20 | | symptoms in common with many other disorders; and |
|---|
| 21 | 21 | | Whereas, in some cases, MG symptoms can worsen to the point of disability, |
|---|
| 22 | 22 | | grave illness, or death, if there are gaps in or an absence of the several crucial health |
|---|
| 23 | 23 | | care treatments that can enable those who endure MG to lead productive, active lives |
|---|
| 24 | 24 | | of normal longevity; and |
|---|
| 25 | 25 | | 1 |
|---|
| 26 | 26 | | 2 |
|---|
| 27 | 27 | | 3 |
|---|
| 28 | 28 | | 4 |
|---|
| 29 | 29 | | 5 |
|---|
| 30 | 30 | | 6 |
|---|
| 31 | 31 | | 7 |
|---|
| 32 | 32 | | 8 |
|---|
| 33 | 33 | | 9 |
|---|
| 34 | 34 | | 10 |
|---|
| 35 | 35 | | 11 |
|---|
| 36 | 36 | | 12 |
|---|
| 37 | 37 | | 13 |
|---|
| 38 | 38 | | 14 - 2 - |
|---|
| 39 | 39 | | LRB-2019/1 |
|---|
| 40 | 40 | | CMH:klm |
|---|
| 41 | 41 | | 2023 - 2024 Legislature |
|---|
| 42 | 42 | | Whereas, MG is found most commonly in adult women under 40 and men over |
|---|
| 43 | 43 | | 60, but is not specific to either gender or any particular ethnic background; and |
|---|
| 44 | 44 | | Whereas, MG is nonhereditary and noncontagious; and |
|---|
| 45 | 45 | | Whereas, 10 to 20 out of every 100,000 Americans are diagnosed with MG, and |
|---|
| 46 | 46 | | support groups exist in Wisconsin for those people; now, therefore, be it |
|---|
| 47 | 47 | | Resolved by the assembly, the senate concurring, That June 2023 is |
|---|
| 48 | 48 | | hereby designated Myasthenia Gravis Awareness Month in Wisconsin. |
|---|
| 49 | 49 | | (END) |
|---|
| 50 | 50 | | 1 |
|---|
| 51 | 51 | | 2 |
|---|
| 52 | 52 | | 3 |
|---|
| 53 | 53 | | 4 |
|---|
| 54 | 54 | | 5 |
|---|
| 55 | 55 | | 6 |
|---|
| 56 | 56 | | 7 |
|---|
| 57 | 57 | | 8 |
|---|